3rd Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$1,930,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Foreign Market Access Issues (including IPR) NAFTA/USMCA International Supply Chain/Buy America U.S.- U.K. Trade Negotiations U.S. - Kenya FTA

LobbyistCovered position, as disclosed
ELISSA ALBEN —
STEPHEN CLAEYS —
JOSEPH TUCKER KNOTT —
EMILY MUELLER —
CATHERINE ROBINSON —

Contacted: State, Dept of (DOS); Natl Economic Council (NEC); White House Office; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Treasury, Dept of; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits

LobbyistCovered position, as disclosed
CAROLINE MOODY SCHELLHAS —

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); Office of the Vice President of the United States; SENATE; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); State, Dept of (DOS); White House Office; HOUSE OF REPRESENTATIVES; Treasury, Dept of; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Office of Management & Budget (OMB)

Health Issues HCR

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform Vaccine Infrastructure Drug Importation

LobbyistCovered position, as disclosed
PAULA BURG —
ROBERT JONES —
JOSEPH TUCKER KNOTT —
EMILY MUELLER —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); White House Office; Food & Drug Administration (FDA); Executive Office of the President (EOP); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Office of the Vice President of the United States; Treasury, Dept of

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency International Reference Pricing/Most Favored Nations

LobbyistCovered position, as disclosed
PAULA BURG —
EMILY MUELLER —
ANGELA WALKER RIEMER —
JENNIFER SWENSON WALTON —

Contacted: Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); White House Office; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of the Vice President of the United States; State, Dept of (DOS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.